Recently, it was suggested that the activation of PD-1/PD-L1 axis led tumor cells resistant to conventional drugs42 and Yan et al. 54 found that elevated cellular PD-L1/PD-1 expression confers acquired resistance to cisplatin in small cell lung cancer cells. This evidence concerns the gene CD274 and small cell lung carcinoma.